MLKL and fibrosarcoma: In another in vitro experiment, silencing of RIPK1 or MLKL in the background of tunicamycin—which can induce necroptosis as well as apoptosis (57, 67)—treatment of L929 cells, a murine fibrosarcoma cell line, triggered a switch from necroptosis to apoptosis (57).